» Articles » PMID: 10201899

P38 Mitogen-activated Protein Kinase Mediates Signal Integration of TCR/CD28 Costimulation in Primary Murine T Cells

Overview
Journal J Immunol
Date 1999 Apr 14
PMID 10201899
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Optimal T cell activation requires two signals, one generated by TCR and another by the CD28 costimulatory receptor. In this study, we investigated the regulation of costimulation-induced mitogen-activated protein kinase (MAPK) activation in primary mouse T cells. In contrast to that reported for human Jurkat T cells, we found that p38 MAPK, but not Jun NH2-terminal kinase (JNK), is weakly activated upon stimulation with either anti-CD3 or anti-CD28 in murine thymocytes and splenic T cells. However, p38 MAPK is activated strongly and synergistically by either CD3/CD28 coligation or PMA/Ca2+ ionophore stimulation, which mimics TCR-CD3/CD28-mediated signaling. Activation of p38 MAPK correlates closely with the stimulation of T cell proliferation. In contrast, PMA-induced JNK activation is inhibited by Ca2+ ionophore. T cell proliferation and production of IL-2, IL-4, and IFN-gamma induced by both CD3 and CD3/CD28 ligation and the nuclear expression of the c-Jun and ATF-2 proteins are each blocked by the p38 MAPK inhibitor SB203580. Our findings demonstrate that p38 MAPK 1) plays an important role in signal integration during costimulation of primary mouse T cells, 2) may be involved in the induction of c-Jun activation and augmentation of AP-1 transcriptional activity, and 3) regulates whether T cells enter a state of functional unresponsiveness.

Citing Articles

Bryostatin-1 enhances the proliferation and functionality of exhausted CD8+ T cells by upregulating MAP Kinase 11.

Li L, Zhao M, van Meurs M, Brouwers-Haspels I, den Dekker R, Wilmsen M Front Immunol. 2025; 15:1509874.

PMID: 39877358 PMC: 11772198. DOI: 10.3389/fimmu.2024.1509874.


TSC2 S1365A mutation potently regulates CD8+ T cell function and differentiation and improves adoptive cellular cancer therapy.

Patel C, Dong Y, Koleini N, Wang X, Dunkerly-Eyring B, Wen J JCI Insight. 2023; 8(21.

PMID: 37788104 PMC: 10721258. DOI: 10.1172/jci.insight.167829.


Akt-2 Is a Potential Therapeutic Target for Disseminated Candidiasis.

Huang L, Ma Y, Guo H, Tang N, Ouyang S, Nuro-Gyina P J Immunol. 2022; 209(5):991-1000.

PMID: 36130126 PMC: 11141526. DOI: 10.4049/jimmunol.2101003.


Tyrosine phosphorylation of NLRP3 by the Src family kinase Lyn suppresses the activity of the NLRP3 inflammasome.

Tang J, Xiao Y, Lin G, Guo H, Deng H, Tu S Sci Signal. 2021; 14(706):eabe3410.

PMID: 34699250 PMC: 8815314. DOI: 10.1126/scisignal.abe3410.


p16 Regulates Cellular Senescence in PD-1-Expressing Human T Cells.

Janelle V, Neault M, LeBel M, De Sousa D, Boulet S, Durrieu L Front Immunol. 2021; 12:698565.

PMID: 34434190 PMC: 8381277. DOI: 10.3389/fimmu.2021.698565.